Diet Protocol SDM Eng
Diet Protocol SDM Eng
Dietary Protocol
research and development studio
S.D.M. s.r.l.
Societ Dietetica Medica
Via dellArtigianato 45
12038 SAVIGLIANO (CN)
Tel. +39 0172 64 80 00
Fax +39 0172 64 88 70
info@menopeso.it
www.dietasdm.it
S
ince 1995/1997 S.D.M., the Societ-Dietetica-Medica (Medical
Dietary Society), has offered effective, easy-to-manage instruments
for the treatment of excess body weight and, consequently, of
weight-related pathologies. The S.D.M. protocol was developed in
collaboration with Professor Marineau, a student of Professor Blackburn,
creator of the first Protein Diet protocol.
Uniquely in Italy, S.D.M. aims not only to support the nutrition expert
in prescribing and managing the dietary therapy, but also to accompany
its customers during their weight-lossprocess.
S.D.M. srl
Societ Dietetica Medica
3
Index
Preface 3
Brief history 5
The method 6
Molecular mechanisms 6
Who the S.D.M. protocolis for 9
Who should NOT use the S.D.M. protocol 9
Advantages of the S.D.M. protocol 10
For the nutrition expert
For the patient
Possible mild side effects of the S.D.M. protocol 11
Carbohydrates 12
Proteins 12
Lipids 13
UNICOMPLEX 13
Fluid intake 13
First appointment 14
Subsequent appointments 14
Attack phase 15
The classic diet 15
Example day 16
The mitigated diet 17
Example day 18
Transition 19
Introduction
The metabolic response of the body to calorie restriction in VLCKD and the
need for gradual increase in calorie intake 19
The four steps of the transition 22
Transition 1stStep 22
Transition 2ndStep 23
Transition 3rdStep 23
Transition 4th Step 23
Transition phase following a weight-losing diet with 3 meals 24
Transition phase following a weight-losing diet with 4 meals 25
Transition phase following a weight-losing diet with 5 meals 26
Transition phase following a weight-losing diet with 6-7 meals 27
Maintenance 29
Conclusions 30
References 31
4
Brief history
I
n 1971, after extensive studies, Professor Blackburn, a professor at
Harvard University, outlined the principles of the Protein Diet, which
he defined as Protein Sparing Modified Fasting (Lidner and Blackburn
1976).
5
THE METHOD
The method
T
he S.D.M. protocolconsists of a normo-protein Very Low Ketogenic Diet (VLCKD < 800 calories)with a low
carbohydrate content (about 50-70g of carbohydrates per day).
I Attack phase: ketogenic metabolism is triggered by the reduced carbohydrate intake. As an accessory phe-
nomenon to lipolysis and the catabolism of the fat reserves of adipose tissue, there is a physiological production
of ketone bodies (aceto-acetate, -hydroxybutyrate, acetone), which are a water-soluble share of energy, readily
available to many of the tissues of the body (brain, heart and muscle). Continuedketogenesis, besidesproviding an
adequate energy supply, is important to ensure the absence of hunger and the feeling of wellbeing throughout
the period of weight-loss.
II Transition phase: gradual reintroduction of traditional foods. In this phase the patient is re-educated to a
healthy and correct lifestyle, in order to optimise and stabilise the results obtained in the attack phase.
III Mediterranean diet: the patient has achieved the overall targets agreed with the nutrition expert and starts
correct long-term nutritional behaviour following the RDAs (Recommended Daily Allowances of nutrients and
energy).
S.D.M. offers specific products for the first and second phases. Transition phase products can also be used in the maintenance
of the dietary equilibrium.
The S.D.M. method provides patient with an amount of high biological value proteins that is calculated on the estimated
ideal weight (from 1 to 1.4 g (max.) of protein/kg ideal body weight/day). The S.D.M. method is therefore safe and suitable
for a broad spectrum of patients, even complex ones, unlike the high-protein diets (EFSA Panel on Dietetic Products Nutrition
and Allergies 2015).
Molecular mechanisms
T
he S.D.M. dietary protocol has a reduced carbohydrate content, which lowers the levels of insulin in the blood
and reduces this hormones antilipolytic activity, in favour of an increase in glucagon levels. These effects result
in an increase in the catabolism of triglyceride reserves mobilised from white adipose tissue,which are hydrolysed by
lipoprotein-lipase and thereby converted into free fatty acids and glycerol (Nelson andCox2014). (Figure 1)
The fatty acids and glycerol are used only in part as an energy substrate: in detail, skeletal muscles use 40% of the free fatty
acids, while hepatocytes transform 10% of the mobilised glycerol into glucose (Alberts, Johnson et al., 2002 ). (Figure 1)
The rest of the glycerol and fatty acids is metabolised in the liver in the processes of gluconeogenesis and ketogenesis,
respectively. Gluconeogenesis represents the metabolic pathway for synthesising glucose from non-carbohydrate sub-
strates and is triggered rapidly in the absence of glucose, through the effect of glucagon. Ketogenesis is the reversible pro-
cess of condensation of acetyl-CoA molecules through which ketone bodies (acetone, acetoacetate and -hydroxy-bu-
tyrate) are synthesised and requires at least 24-48 hours to be activated (Nelson and Cox 2014). (Figure 2)
In the lack of glucose, ketone bodies are readily used as a source of energy by skeletal muscles, the central nervous
system and cardiac tissue. In these tissues, ketone bodies are oxidized to acetyl-CoA, the metabolic substrate of the
Krebs cycle. At the same time, the nutritional characteristics of the S.D.M. products (proteins of high biological value
6
THE METHOD
and limited carbohydrate content), ensure the stability of blood glucose, through the mechanism of hepatic and renal
gluconeogenesis (Nelson andCox2014). (Figure 1)
The latter phenomenon promotes a basal secretion of insulin which helps to keep the blood ketone levels stable: in fact,
a feedback mechanism between the levels of ketone bodies and the release of insulin is triggered. In this regard, insulin
plays a modulatory role on ketogenesis itself, making it impossible for pathological keto-acidosis, typical of type I or
insulin-dependent diabetes mellitus, to become established (Alberts, Johnson et al. 2002, Nelson and Cox 2014).
During the S.D.M. diet, the main source of energy comes from the catabolism of the lipidstores, thus causing an
efficient, rapid and steady weight loss at the expense of fat mass. In parallel, the lean body mass is preserved, thanks to
the contribution of normoprotein S.D.M. foods, thus improving the patients body composition.
In summary, the S.D.M. protocol, managed by a nutrition expert, is safe and effective for a wide range of patients,
including complex individuals.
Protein supply
Restricted supply of
Lactate carbohydrates
Gluconeogenesis
Aminoacids
Glucose
Ketone
bodies Other organs
Triglycerides Urine
Figura 1. Thanks to the restricted intake of carbohydrates, the SDM diet lowers the levels of insulin in the blood and reduces the activity of this hormone,
promoting lipolysis and consequent ketogenesis, thereby providing the energy required to the central nervous system (ketones readily cross the blood-
brain barrier) and other tissues. The contribution of pre-assimilable protein supplements, of high biological value, effectively protects muscle mass.
7
THE METHOD
Gluconeogenesis Glycolysis
Glucose Glucose
Glucose-6-phosphate Lipolysis
Ketone bodies
Oxalacetate Citrate
Acetate
TCA cycle
Malonate alpha-Ketoglutarate
CO2
Fumarate Succinate
Figura 2. Metabolic pathways activated in liver cells as a result of low blood glucose levels: gluconeogenesis,which produces glucose molecules, and
ketogenesis, which produces ketone bodies. The same pathways are used in the opposite direction in, respectively, gluco-dependent cells (adrenal cells
and red blood cells) and skeletal muscle and the central nervous system as a source of metabolic energy.
8
THE METHOD
Overweight individuals with comorbid conditions(type II diabetes mellitus, dyslipidaemia, metabolic syndrome,
nocturnal apnoea syndrome, asthma) (Mobbs, Mastaitis et al. 2013, Paoli, Rubini et al. 2013, Feinman, Pogozelski et
al. 2015).
Pre-bariatric or obese patients, candidates for other types of surgery, to reduce the surgical/anaesthesiological
risk (Lidner and Blackburn 1976, Paoli, Rubini et al. 2013, Sukkar, Signori et al. 2013, Vesely and DeMattia 2014,
Castaldo, Palmieri et al. 2015).
Women who remain obese or overweight at the end of pregnancy and breastfeeding (Sumithran, Prendergast et
al. 2013).
Males and females with obesity-related Infertility and polycystic ovary syndrome (Mavropoulos, Yancy et al. 2005,
Kulak andPolotsky 2013).
Obese and over weight patients with migraine (Maggioni, Margoni et al. 2011, Di Lorenzo, Coppola et al. 2015).
Patients with severe liver failure (active chronic hepatitis, cirrhosis of the liver)
Patients with renal failure (serum creatinine greater than 1.5 mg/dl or GFR <60 ml/min).
Patients with serious cardiac disorders: heart failure, atrioventricular block, arrhythmias.
Patients who have had a myocardial infarction or stroke in the 3 months prior to beginning the dietary treatment.
Individuals under treatment with non-potassium-sparing diuretics who have unbalanced hypokalaemia.
(Mobbs, Mastaitis et al. 2013, Paoli, Rubini et al. 2013, Sussman, Ellegood et al. 2013, Armeno, Caraballo et al. 2014,
Castaldo, Palmieri et al. 2015, Paoli, Bianco et al. 2015, Paoli, Bosco et al. 2015).
9
THE METHOD
Medicalised protocol.
Simplicity of prescription.
Lean body mass preserved (Pezzana, Amerio et al. 2014, EFSA Panel on Dietetic Products Nutrition andAllergies2015).
Durable results.
10
THE METHOD
Dizziness
Postural hypotension Interview Hyponatraemia Increase intake of fluids
Nausea Clinical examination causinghypovolaemia and sodium
Tachycardia
Fibre intake
Anti-diarrheal agent
Change of diet
Diarrhoea Interview Evaluate hydration and temporary
Decreased intake of fibre
suspension of the diet
11
MACRO- AND MICRO-NUTRIENTS IN THE S.D.M. DIET
T
he S.D.M. protocol is designed to provide about 50-70 g/day of carbohydrates, which leads, in order, to lowering
the levels of insulin and reducing its anti-lipolytic activity. This is important to ensure a lipolytic process (and therefore
weight loss) that is constant and moderate, as well as stable ketogenesis, useful for eliminating hunger pangs and for
conferring a feeling of well-being during the diet.
The amount of carbohydrates in the protocol is also essential to providea supply of energy to the gluco-dependent cells
that do not contain mitochondria (red blood cells, adrenal cells) (Pezzana, Amerio et al. 2014, EFSA Panel on Dietetic Products
Nutrition andAllergies 2015).
The daily intake should not, however, exceed 1 +/-0,1 g/kg of ideal weight. Higher values inhibit ketogenesis and cancel
the anorectic effect.
The carbohydrates eaten during the dietary therapy can be complex (fibre) or simple, present in vegetables and S.D.M.
products themselves. In order to control the daily glucose intake, S.D.M. proposes a list of vegetables with a low
carbohydrate content (group 1), which the patient can consume at will, and a second list (group 2) of those that should
be consumed in only limited quantities.
Proteins
T
he S.D.M. diet is classified among normo-protein protocols (0.9-1.4 g/kg of ideal weight, table 1) (Pezzana, Amerio et
al. 2014, EFSAPanel on Dietetic Products Nutrition and Allergies 2015). S.D.M. products are made using high biological
value proteins all from the European foodchain.
Table 1. Minimum and maximum recommended protein intake in obese patients about 40 years old according to the EFSA 2015 (EFSA Panel on Dietetic
Products Nutrition and Allergies 2015).
12
MACRO- AND MICRO-NUTRIENTS IN THE S.D.M. DIET
Lipids
T
he S.D.M. protocol is designed to include indispensable integration with extra virgin olive oil (10 grams,
corresponding to about 2 teaspoons), a source of essential fatty acids. This lipid intake is also helpful for promoting
good biliary function (Pezzana, Amerio et al. 2014, EFSA Panel on Dietetic Products Nutrition and Allergies 2015).
Complementary intake of S.D.M. OMEGA 3 is also proposed, since this helps to optimise the catabolism of triglycerides
and, at the same time, has a protective effect on the cardiovascular system.
UNICOMPLEX
Ingredients per dose (2 sachets) RDA / dose
I
t is an indispensable part of the S.D.M. protocol to Potassium 2000 mg 100
supplement the micro-elements, present in the vegetables Calcium 800 mg 100
allowed, by using S.D.M. UNICOMPLEX, a unique supplement Magnesium 375 mg 100
that contains a full complement of mineral salts and vitamins. Zinc 10 mg 100
Manganese 2 mg 100
Of the possible side effects that may occur during the S.D.M.
Copper 1 mg 100
dietary therapy, 95% are due to inadequate supplementation
of micro-nutrients. A ketogenic diet does, in fact, cause a Iodine 150 mcg 100
physiological increase in the renal excretion of mineral salts Selenium 55 mcg 100
(potassium, sodium, calcium, magnesium), which passively Chrome 40 mcg 100
follow the renal clearance of ketone bodies.
Vitamin C 80 mg 100
Excluding some macronutrients that are a source of mineral Vitamin PP 16 mg 100
salts from the daily diet can contribute to further reducing the Vitamin E 12 mg 100
basic reserves. Pantothenic acid 6 mg 100
Guaranteeing the correct supply of mineral salts and vitamins Vitamin B2 1,4 mg 100
is essential in order to maintain optimal cell function: for this
Vitamin B6 1,4 mg 100
reason, the S.D.M. UNICOMPLEX completely covers the daily
Vitamin B1 1,1 mg 100
requirements of all the main micro-nutrients (table 2).
Vitamin A 800 mcg 100
Folic acid 200 mcg 100
Table 2. Micro-nutrient formulation of S.D.M. UNCOMPLEX. Vitamin B8 50 mcg 100
Vitamin D 5 mcg 100
Vitamin B12 2,5 mcg 100
Fluid intake
I
t is recommended that the patient drinks at least 2 litres of water per day, which can be in the
form of unsweetened infusions, since this is indispensable to compensate for the increased
requirement during the dietary therapy (Pezzana, Amerio et al. 2014, EFSA Panel on Dietetic
Products Nutrition and Allergies 2015).
13
MANAGEMENT OF THE PATIENT
I
n the field of nutrition, it is fundamental that a relationship of mutual trust is
established between the patient and the care professional. To this end, it
is essential to identify what has motivated the patient to start a diet and,
consequently, his or her expectations about it. A good initial approach leads
to greater compliance both in the short-term and in the long-term, which,
together with the efficacy and simplicity of management of the protocol,
ensures clinical success.
During the first interview, it is important to assess:
Based on the clinical and individual needs of the patient, a personalised S.D.M. diet is prescribed: this can be administered
in the classic or mitigated form (see next chapter).
Advice: faced with a severely overweight patient, it is important not to make the subject feel guilty and to propose
reasonably attainable intermediate objectives. It is advisable to fix the date of the second follow-up appointment 10-15
days after the first appointment, to ensure the patients real compliance and proper management of the protocol and to
evaluate the first results.
Subsequent appointments
I
t is suggested that follow-up visits are performed on a monthly basis, although
they can be more or less frequent at the discretion of the care professional.
If ketogenesis is maintained for a prolonged period, it is advisable to repeat the
blood-biochemistry analyses.
14
MANAGEMENT OF THE PATIENT
T
he S.D.M. protocol includes a first phase in which all the meals are replaced by S.D.M. products, associated with
vegetables with a low content of carbohydrates. It is essential to provide supplementary trace elements, mineral salts
and vitamins. S.D.M. has developed a specific supplement for this purpose, which simplifies the management for
both the nutritionist and the patient: S.D.M. UNICOMPLEX.
Supplementation:
UNICOMPLEX: 2 sachets/day (table 2), indispensable.
Omega 3: 2 capsules/day, optional, promotes the catabolism of triglycerides and lowers cardiovascular risk,
Fibromanna: 1 sachet/day, optional, promotes intestinal transit,
Probio (lactic ferments): 2 capsules/day, optional, rebalances the intestinal flora,
For women, Draincell: 2 caps in 1 litre of water, optional, in the case of water retention.
15
LA TERAPIA DIETETICA S.D.M.
S.D.M. Cappuccino
S.D.M. Zwieback with 2/3 teaspoons of S.D.M.low calorie jam/hazelnut spreadand coffee
S.D.M. Shortbreadwith tea
S.D.M. Sea biscuitswith tea
S.D.M. Milk cornflakes
S.D.M. Pancake
S.D.M. Bar
S.D.M. Wafer
S.D.M. Shortbread
S.D.M. Yoghurt-tasting drink
S.D.M. Stuzzichelle
S.D.M. Macaroons
S.D.M. Hot chocolate
S.D.M. Readymade puddings
S.D.M. Procrockbiscuit
S.D.M. Soya nuts
S.D.M. Peach tea
S.D.M. Omelette
S.D.M. Risotto
S.D.M. Breadsticks with salad
S.D.M. Vegetable soup
S.D.M. Soup
16
LA TERAPIA DIETETICA S.D.M.
T
he S.D.M. protocol offers the possibility of following the diet while including a serving of meat, fish or eggs, during
one of the main meals in replacement of an S.D.M. food, together with vegetables with a low carbohydrate content.
This allows ketogenesis to be triggered, with resulting weight loss, and at the same time grants the patient a discrete
conviviality. The mitigated diet can also be considered the phase following the classic diet. Supplementation of trace
elements, mineral salts and vitamins (S.D.M. UNICOMPLEX) is essential in this protocol, too.
Supplementation:
UNICOMPLEX: 2 sachets/day (table 2), indispensable.
Omega 3: 2 capsules/day, optional, promotes the catabolism of triglycerides and lowers cardiovascular risk,
Fibromanna: 1 sachet/day, optional, promotes intestinal transit,
Probio (lactic ferments): 2 capsules/day, optional, rebalances the intestinal flora,
For women, Draincell: 2 caps in 1 litre of water, optional, in the case of water retention.
S.D.M. Bar
S.D.M. Wafer
S.D.M. Shortbread
S.D.M. Yoghurt-tasting drink
S.D.M. Stuzzichelle
S.D.M. Macaroons
S.D.M. Hot chocolate
S.D.M. Readymade puddings
S.D.M. Procrock biscuit
S.D.M. Soya nuts
S.D.M. Peach tea
18
LA TERAPIA DIETETICA S.D.M.
The transition
Introduction
For this reason it is essential to re-introduce the foods, and therefore calorie intake, gradually, so as to induce an
equally gradual and proservingal increase in the subjects basal calorie consumption (Gripeteg, Torgerson et al. 2010). As
demonstrated by the study by Gripeteget al. the duration of the transition phase and the graduality of calorie increase,
together, enable achievement of the bestmedium- and long-term results with regards to both weight maintenance
and some clinical parameters.
In this study, at the end of a VLCKD protocol (<800 calories/day) lasting 12 weeks, two groups of patients who achieved a significant percentage
reduction of weight (about - 18%) began a transition phase of different duration.
In the long-term (52 weeks), the group of 65 patients that followed a transition phase lasting 6 weeks maintained the results achieved with the
VLCKD, compared to the group of 58 patients who followed a transition phase of only 1 week (p = 0.006 ).
In the same study, the patients in the group that followed a transition period lasting 6 weeks maintained, over time, a significant reduction
in waist circumference and systolic and diastolic blood pressure, compared to patients who followed a transition phase lasting just 1 week
(Gripeteg, Torgerson et al. 2010).
19
In the light of the foregoing considerations, it is advised that the transition phase lasts as long as the phase of weight
reduction and that it is divided into four steps.
Each step involves an increase of about 200 Kcal (Figure 3), achieved by:
An increase in the proserving of carbohydrates, using foods with a low glycaemic index (GI);
tion
he transi
during t
the BM
re ase in
e inc
ro g ressiv
P
During the different steps of the transition phase it is critical that the protein intake is adequate for the needs of the
individual subject in order for his or her lean mass to be safeguarded and so that the satiating effect of proteins promotes
the patients good compliance until completion of the dietary protocol.
The observations of MargrietWesterterp-Plantenga, a leading international expert on the subject, confirm that, at the end
of a VLCKD protocol in which there has been a weight loss of 5-10%, a significant supply of proteins in the transition phase
and during maintenance affords better stabilisation of results in the medium- and long-term (Westerterp-Plantenga 2004,
Lejeune, Kovacs et al. 2005).
20
In the above study, at the end of a VLCKD protocol (<800 calories/day) lasting 4 weeks, two groups of previously randomised patients, after
having obtained a significant reduction in percentage of body weight (between 5% and 10% ), underwent a transition phase and maintenance
with two diets containing different percentages of protein.
Over a period of 12 months, compared to the group of 60 patients who followed a transition phase with a protein content of 15% of the daily
calorie intake, the group of 53 patients who followed a transition phase with a protein content of 18% of the daily calorie intake had:
(Westerterp-Plantenga 2004).
In order to ensure optimal protein intake, without increasing the calorie content of each step excessively, the protocol for
the transition phase includes the daily consumption of a defined number of S.D.M. protein foods, established on the
basis of the course of the VLCKD.
Another interesting aspect, which can influence weight gain, is the number of meals in a day. Investigations carried out
so far have shown a lower risk of metabolic syndrome when calorie intake is distributed through the day in four meals
rather than in three.
For example, in a study by Chapelotof percentage changes in fat mass and plasma concentrations of leptin in relation to the number of meals
in the day, it was seen that the subjects who passed from 4 to 3 daily meals had increases of both fat mass and the level of circulating leptin.
The passage, in the same subjects, from 3 to 4 daily meals helpedto reduce fat mass and lower leptin levels (Chapelot, 2006).
In a similar study, Fabry showed the different incidence of clinical aspects of the metabolic syndrome betweena group of patients receiving
three or fewer meals in a day compared to a group receiving five or more than five daily meals.
The incidences of: excess weight, high cholesterol and insulin resistance were higher among the subjects receiving three meals (or even fewer)
in a day. In contrast, the subjects who received five or more meals in a day had significantly lower incidence of these conditions and a higher
frequency of laboratory values within the normal range (Fabry, 1994).
In the light of the above considerations, it is recommended that the patient receives at least five daily meals, so as to
divide the calorie supply of the macronutrients appropriately.
With respect to the calorie intake of carbohydrates, the concept of avoiding carbohydrates with a high glycaemic index
remains fundamental (Brand-Miller, Holt et al., 2002, Barclay, Petocz et al. 2008 Vesely and DeMattia 2014), with particular
attention to the overall glycaemic load of the diet.
This aspect enables insulin secretion to be kept under control, thus avoiding massive reactivation of lipo-synthesis,
which underlies the increase in adipose tissue. According to most experts, a total daily glycaemic load of less than 80
would significantly reduce weight gain after the slimming programme and reduce the risk of insulin resistance in the
maintenance phase (Brand-Miller 2008, Afaghi 2012). The transition phase therefore incorporates a gradual reintroduction
of carbohydrates, choosing foods with a low glycaemic index and moderating their amount, so as to reduce the glycaemic
load of each meal and not exceed the recommended daily total glycaemic load (Vesely and DeMattia 2014).
21
LA TERAPIA DIETETICA S.D.M.
Introduction of fruit Introduction of dairy products Introduction of oily seeds Increase of calories through the
+ + + same foods introduced in the
Introduction of meat/fish/vegetable Introduction of cereals Introduction of legumes preceding steps
protein foods at lunch and dinner
Transition 1stStep
Introduction of fruit
FRUIT:
Fresh and ideally in season, 1 serving of 100-150 g *.
*Theserving of fruitcan be replaced by centrifuged fruit juice or fruit extract.
2nd DISH:
Meat (1 servingof about 100-150 g).
Lean red (the recommended amount is 1 servingper week): tenderloin, sirloin, topside, silverside, rump, lean thick flank,
lean beef-burger, carpaccio.
White: chicken, turkey, rabbit.
Cold cuts (1 serving of about 60 g): bresaola, cooked ham, raw ham or bacon with the fat removed.
Vegetable-based protein foods (1 servingof about 150-200 g): tofu, seitan, soya, tempeh.
22
LA TERAPIA DIETETICA S.D.M.
Introduction of cereals
CEREALS:
Low GI S.D.M. tagliatelle, spelt, wheat, barley, wholegrain rice, basmati rice, black rice, amaranth, buckwheat*, quinoa*.
Low-carbohydrate wholemeal bread made of rye or spelt, biscuits with a low GI, crispbread.
*although these are not cereals, from a purely nutritional point of view, they can be considered analogues of cereals.
Introduction of legumes
OILY SEEDS:
Walnuts, hazelnuts, almonds
LEGUMES:
Lentils, beans, chickpeas, peas, broad beans, soya beans, edamame.
23
LA TERAPIA DIETETICA S.D.M.
24
LA TERAPIA DIETETICA S.D.M.
A 2nd dish: all the foods in the A 2nd dish: all the foods in the
permitted list are allowed permitted list are allowed
except low-fat cheeses except low-fat cheeses
1 SDM food
+ +
+
SDM food 1 servingof unrestricted SDM food 1 servingof unrestricted
1 serving of fruit
vegetables vegetables
+ +
condiment: 1 tablespoon of condiment: 1 tablespoon of
extra virgin olive oil extra virgin olive oil
A 2nddish
125 g of yoghurt / 1 egg / 2
+
slices of lean cold cuts / 50 g A 2nddish
1 servingof unrestricted
of feta / 1 SDM transition food +
vegetables
+ SDM food SDM food 1 servingof unrestricted
+
1 serving of fruit + + vegetables
condiment: 1 tablespoon of
+ 1 serving of fruit 1 serving of fruit +
extra virgin olive oil
2 slices of wholemeal bread condiment: 1 tablespoon of
+
(type, sandwich loaf )/low GI extra virgin olive oil
2 slices of wholemeal bread
biscuit / 30 g of muesli
(type, sandwich loaf
25
LA TERAPIA DIETETICA S.D.M.
A 2nddish
125 g of yoghurt / 1 egg / 2 A 2nddish
+
slices of lean cold cuts / 50 g +
1 servingof unrestricted
of feta / 1 SDM transition food 1 serving of unrestricted
vegetables
+ SDM food SDM food vegetables
+
1 serving of fruit + + +
condiment: 1 tablespoon of
+ 1 serving of fruit 1 serving of fruit condiment 15g of extra virgin
extra virgin olive oil
2 slices of wholemeal bread olive oil
+
(type, sandwich loaf )/low GI +
2 slices of wholemeal bread
biscuit / 30 g of muesli SDM food
(type, sandwich loaf )
26
LA TERAPIA DIETETICA S.D.M.
A 2nddish
125 g of yoghurt / 1 egg / 2
+ A 2nddish
slices of lean cold cuts / 50 g
1 servingof unrestricted +
of feta / 1 SDM transition food
vegetables 1 servingof unrestricted
+ SDM food SDM food
+ vegetables +
1 serving of fruit + +
condiment: 1 tablespoon of condiment: 1 tablespoon of
+ 1 serving of fruit 1 serving of fruit
extra virgin olive oil extra virgin olive oil
2 slices of wholemeal bread
+ +
(type, sandwich loaf/low GI
2 slices of wholemeal bread SDM food
biscuit / 30 g of muesli
(type, sandwich loaf
27
THE S.D.M. DIETARY THERAPY
Supplementation:
UNICOMPLEX: indispensable in the first three steps of the transition.
The recommended dose is 2 sachets during step 1, 1sachet during steps 2-3.
During step 4, supplementation with Unicomplex
is recommended at the discretion of the care professional.
Omega 3: 2 capsules/day, optional, promotes catabolism of triglycerides and lowers cardiovascular risk,
Fibromanna: 1 sachet/day, optional, promotes intestinal transit,
Probio (lactic ferments): 2 capsules/day, optional, rebalances intestinal flora,
For women Draincell: 2 caps in 1 litre of water, optional, in the case of water retention.
Unrestricted vegetables:
Lettuce, Corn salad, Belgian endive, Rocket, Chicory, Endive, Escarole, Treviso salad, Red
and green radicchio, Radish, Chard, Spinach, Celery, Turnip greens, Green peppers, Fennel,
Broccoli, Cauliflower, Cabbage, Sprouting broccoli, Romanesco, Headed cabbage, Savoy
cabbage, Chinese cabbage, Champignon mushrooms, Caesars mushrooms, Bolelus, Soya
sprouts, Zucchini, Zucchini flowers, Cucumber, Cardoon, Aubergine, Tomatoes, Yellow and red
peppers, Artichokes, Asparagus, Brussels sprouts, String beans, Yellow squash, Turnips, Dandelion.
Condiments:
Extra virgin olive oil: consume the amount presentedfor each step.
Spices: all dried spices, such as oregano, curry, thyme, laurel, etc., are allowed
On pasta: tomato sauce, pesto sauce, fishsauce.
Physical activity:
Regular physical activity is recommended: walking, cycling, swimming for at least 40-45 minutes. The physical exercise can be
intensified gradually during the various steps of the transition phase and can also include more vigorous activities such as running,
tone-up, aerobics, etc.
28
THE S.D.M. DIETARY THERAPY
Maintenance
O
ver the years, numerous studies have examined the strategies for maintaining the results obtained with a VLCKD
dietary protocol in the medium- and long-term (Desjeux, Gernez-Lestradet et al. 1982, Romon, Edme et al. 1993,
Brand-Miller, Holt et al. 2002, OReardon, Ringel et al. 2004, Wing and Phelan 2005, Chapelot, Marmonier et al. 2006,
Thomas, Elliott et al. 2007, Livesey, Taylor et al. 2008, Paddon-Jones, Westman et al. 2008, Larsen, Dalskov et al. 2010, Larsen,
Dalskov et al. 2010).
Carry out moderate, aerobic physical activity regularly for 45-60 minutes.
Eat at least five servings of fruit and vegetables, since these are rich in fibre, vitamins, mineral salts and anti-oxidants.
Maintain a proper level of body fluid by drinking at least 1.5-2 litres of water each day.
Start the day with a balanced breakfast so that Ghrelin levels are kept under control, thereby reducing hunger
during the day (Foster-Schubert, Overduin et al. 2008).
Distribute the calorie requirements of the day in at least four meals, preferably respecting the following percentages:
breakfast 27%, lunch 36%, snack 13% and dinner 24%.
- Is not less than 20% of the total calorie requirements, in order to preserve lean mass;
- Is distributed evenly within each meal, to reduce its glycaemic load and have a greater satiating effect
(Chapelot, Marmonier et al. 2006, Tom 2009).
Reduce the overall contents of fats, particularly saturated fats, of animal origin, and hydrogenated ones, of vegetable
origin.
Respect the RDA for mineral salts, vitamins and trace elements.
29
Conclusions
T
he effectiveness of the whole VLCKD protocol is closely
related to strict compliance with the various aspects of the
rationale governing the four steps of the transition phase.
At the end of the attack phase, the preserved lean body mass,
which is guaranteed by the optimal protein supply during the
phase of weight loss, and the progressive increase in calories, with
foods that have a low glycaemic load, in each of the four steps of
the transition phase,enable metabolism to return to appropriate
levels.
30
References
Afaghi A., Ziaee A. Low glycemic index-glycemic Foster-Schubert, K. E., J. Overduin, C. E. Prudom, J. Nelson, D. and M. Cox (2014). I principi di
load diet and diabetes management. LAP Liu, H. S. Callahan, B. D. Gaylinn, M. O. Thorner and biochimica di Lenhinger, Zanichelli.
Lambert Academic Publishing 2007. D. E. Cummings (2008). Acyl and total ghrelin are OReardon, J. P., B. L. Ringel, D. F. Dinges, K.
Alberts, B., A. Johnson, J. Lewis, M. Raff, M. Roberts suppressed strongly by ingested proteins, weakly C. Allison, N. L. Rogers, N. S. Martino and A. J.
and P. Walter (2002). Molecular Biology of the Cell, by lipids, and biphasically by carbohydrates. J Stunkard (2004). Circadian eating and sleeping
Garland Science. Clin Endocrinol Metab 93(5): 1971-1979. patterns in the night eating syndrome. Obes Res
Armeno, M., R. Caraballo, M. Vaccarezza, M. J. Gibson, A. A., R. V. Seimon, C. M. Lee, J. Ayre, 12(11): 1789-1796.
Alberti, V. Ros, S. Galicchio, E. S. de Grandis, G. J. Franklin, T. P. Markovic, I. D. Caterson and A. Obesity, T. N. T. F. o. t. P. a. T. o. (August 25, 1993).
Mestre, N. Escobal, P. Matarrese, R. Viollaz, A. Sainsbury (2015). Do ketogenic diets really Very Low-Calorie Diets., JAMA. 270: 967-974.
Agostinho, C. Dez, A. Cresta, A. Cabrera, V. Blanco, suppress appetite? A systematic review and Paddon-Jones, D., E. Westman, R. D. Mattes, R. R.
H. Ferrero, V. Gambarini, P. Sosa, C. Bouquet, L. meta-analysis. Obes Rev 16(1): 64-76. Wolfe, A. Astrup and M. Westerterp-Plantenga
Caramuta, S. Guisande, B. Gamboni, A. Hassan, Gripeteg, L., J. Torgerson, J. Karlsson and A. K. (2008). Protein, weight management, and
L. Pesce, L. Argumedo, C. Dlugoszewski, M. Lindroos (2010). Prolonged refeeding improves satiety. Am J Clin Nutr 87(5): 1558S-1561S.
G. DeMartini and L. Panico (2014). [National weight maintenance after weight loss with very- Paoli, A., A. Bianco and K. A. Grimaldi (2015). The
consensus on the ketogenic diet]. Rev Neurol low-energy diets. Br J Nutr 103(1): 141-148. Ketogenic Diet and Sport: A Possible Marriage?
59(5): 213-223. JAMA (August 25, 1993). Very Low-Calorie Diets., Exerc Sport Sci Rev 43(3): 153-162.
Barclay, A. W., P. Petocz, J. McMillan-Price, V. JAMA, The National Task Force on the Prevention Paoli, A., G. Bosco, E. M. Camporesi and D. Mangar
M. Flood, T. Prvan, P. Mitchell and J. C. Brand- and Treatment of Obesity. 270: 967-974. (2015). Ketosis, ketogenic diet and food intake
Miller (2008). Glycemic index, glycemic load, Kulak, D. and A. J. Polotsky (2013). Should the control: a complex relationship. Front Psychol 6:
and chronic disease risk--a meta-analysis of ketogenic diet be considered for enhancing 27.
observational studies. Am J Clin Nutr 87(3): 627- fertility? Maturitas 74(1): 10-13. Paoli, A., A. Rubini, J. S. Volek and K. A. Grimaldi
637. Larsen, T. M., S. Dalskov, M. van Baak, S. Jebb, (2013). Beyond weight loss: a review of the
Blackburn G.L. Break Trough. How to finally lose A.Kafatos, A. Pfeiffer, J. A. Martinez, T. Handjieva- therapeutic uses of very-low-carbohydrate
the weight you want and keep it off. Harper Darlenska, M. Kunesov, C. Holst, W. H. Saris and (ketogenic) diets. Eur J Clin Nutr 67(8): 789-796.
Collins Publishers 2007. A. Astrup (2010). The Diet, Obesity and Genes Pezzana, A., M. Amerio, G. Fatati, L. Caregaro,
Brand-Miller, J. C., S. H. Holt, D. B. Pawlak and J. (Diogenes) Dietary Study in eight European F. Muratori, G. Rovera and M. Zanardi (2014). La
McMillan (2002). Glycemic index and obesity. countries - a comprehensive design for long-term dieta chetogenica. Fondazione ADI: Position
Am J Clin Nutr 76(1): 281S-285S. intervention. Obes Rev 11(1): 76-91. Paper, Fondazione ADI: Position Paper. 6.
Castaldo, G., V. Palmieri, G. Galdo, L. Castaldo, Larsen, T. M., S. M. Dalskov, M. van Baak, S. A. Romon, M., J. L. Edme, C. Boulenguez, J. L.
P. Molettieri, A. Vitale and L. Monaco (2015). Jebb, A. Papadaki, A. F. Pfeiffer, J. A. Martinez, T. Lescroart and P. Frimat (1993). Circadian variation
Aggressive nutritional strategy in morbid obesity Handjieva-Darlenska, M. Kuneov, M. Pihlsgrd, of dietinduced thermogenesis. Am J Clin Nutr
in clinical practice: Safety, feasibility, and effects S. Stender, C. Holst, W. H. Saris, A. Astrup and O. e. 57(4): 476-480.
on metabolic and haemodynamic risk factors. Diet, and Genes (Diogenes) Project (2010). Diets Sukkar, S. G., A. Signori, C. Borrini, G. Barisione,
Obes Res Clin Pract. with high or low protein content and glycemic C. Ivaldi, C. Romeo, R. Gradaschi, N. Machello,
Chapelot, D., C. Marmonier, R. Aubert, C. Allgre, index for weight-loss maintenance. N Engl J Med E. Nanetti and A. L. Vaccaro (2013). Feasibility
N. Gausseres, M. Fantino and J. Louis-Sylvestre 363(22): 2102-2113. of proteinsparing modified fast by tube
(2006). Consequence of omitting or adding a Leibel R.L. Changes in energy expenditure (ProMoFasT) in obesity treatment: a phase II
meal in man on body composition, food intake, resulting from altered body weight. NEJM pilot trial on clinical safety and efficacy (appetite
and metabolism. Obesity (Silver Spring) 14(2): 1995;332(10):621-628. control, body composition, muscular strength,
215-227. Lejeune, M. P., E. M. Kovacs and M. S. Westerterp- metabolic pattern, pulmonary function test).
Desjeux, J. F., C. Gernez-Lestradet, I. Deschamps, Plantenga (2005). Additional protein intake Med J Nutrition Metab 6: 165-176.
S. Machinot, F. Rolland and H. Lestradet (1982). limits weight regain after weight loss in humans. Sumithran, P., L. A. Prendergast, E. Delbridge,
Circadian metabolic rhythms in obese children. Br J Nutr 93(2): 281-289. K. Purcell, A. Shulkes, A. Kriketos and J. Proietto
Ann Nutr Metab 26(2): 106-110. Lidner, P. G. and G. L. Blackburn (1976). (2013). Ketosis and appetite-mediating nutrients
Di Lorenzo, C., G. Coppola, G. Sirianni, G. Di multidisciplinary approach to obesity utilizing and hormones after weight loss. Eur J Clin Nutr
Lorenzo, M. Bracaglia, D. Di Lenola, A. Siracusano, fastimg modified by protein-sparing therapy, 67(7): 759-764.
P. Rossi and F. Pierelli (2015). Migraine Obesity/Bariatric Med. 5. Sussman, D., J. Ellegood and M. Henkelman (2013).
improvement during short lasting ketogenesis: a Livesey, G., R. Taylor, T. Hulshof and J. Howlett A gestational ketogenic diet alters maternal
proof-of-concept study. Eur J Neurol 22(1): 170- (2008). Glycemic response and health--a metabolic status as well as offspring physiological
177. systematic review and meta-analysis: relations growth and brain structure in the neonatal mouse.
EFSA Panel on Dietetic Products Nutrition and between dietary glycemic properties and health BMC Pregnancy Childbirth 13: 198.
Allergies, N. (2015). Scientific opinion on the outcomes. Am J Clin Nutr 87(1): 258S-268S. Thomas, D. E., E. J. Elliott and L. Baur (2007). Low
essential composition of total diet replacement Maggioni, F., M. Margoni and G. Zanchin (2011). glycaemic index or low glycaemic load diets for
for weight control, EFSA Journals. 13: 3957-4008. Ketogenic diet in migraine treatment: a brief but overweight and obesity. Cochrane Database Syst
Fabry P, Hejl Z. Frequency of meals. Its relation to ancient history. Cephalalgia 31(10): 1150-1151. Rev(3): CD005105.
overweight, hypercholesterolaemia and decreased Marineau, J. M. (September 2004). Mise au point Tom, D. (2009). Proteine et acides amins: quel
glucose-tolerance. Lancet. 1994;2(7360):614-5 sur le protocole du jeune proteine, J. Med. Esth. et besoins pour quelles fonctions?, Symposium
Feinman, R. D., W. K. Pogozelski, A. Astrup, R. K. Chir. Derm. XXXI: 149-155. International de Nutrition.
Bernstein, E. J. Fine, E. C. Westman, A. Accurso, L. Mavropoulos, J. C., W. S. Yancy, J. Hepburn and Vesely, J. M. and L. G. DeMattia (2014). Obesity:
Frassetto, B. A. Gower, S. I. McFarlane, J. V. Nielsen, E. C. Westman (2005). The effects of a low- dietary and lifestyle management. FP Essent 425:
T. Krarup, L. Saslow, K. S. Roth, M. C. Vernon, J. S. carbohydrate, ketogenic diet on the polycystic 11-15.
Volek, G. B. Wilshire, A. Dahlqvist, R. Sundberg, ovary syndrome: a pilot study. Nutr Metab (Lond) Westerterp-Plantenga, M. S. (2004). Fat intake
A. Childers, K. Morrison, A. H. Manninen, H. M. 2: 35. and energy-balance effects. Physiol Behav 83(4):
Dashti, R. J. Wood, J. Wortman and N. Worm Mobbs, C. V., J. Mastaitis, F. Isoda and M. Poplawski 579-585.
(2015). Dietary carbohydrate restriction as the (2013). Treatment of diabetes and diabetic Wing, R. R. and S. Phelan (2005). Long-term
first approach in diabetes management: critical complications with a ketogenic diet. J Child weight loss maintenance. Am J Clin Nutr 82(1
review and evidence base. Nutrition 31(1): 1-13. Neurol 28(8): 1009-1014. Suppl): 222S-225S.